Trial Profile
Efficacy trial of ingestion of the developmental code USRP-003
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2018
At a glance
- Drugs USRP 003 (Primary)
- Indications Nocturia
- Focus Therapeutic Use
- Sponsors Kao Corporation
- 07 Sep 2018 New trial record